We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
Cap. Flow
+$7.27B
Cap. Flow %
9.7%
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$3.04B
2
MSFT icon
Microsoft
MSFT
+$830M
3
AMZN icon
Amazon
AMZN
+$550M
4
JNJ icon
Johnson & Johnson
JNJ
+$483M
5
AAPL icon
Apple
AAPL
+$470M

Sector Composition

Rank Sector Weight
1 Technology 18.7%
2 Consumer Discretionary 13.75%
3 Healthcare 12.4%
4 Financials 7.81%
5 Industrials 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TROW icon
326
T. Rowe Price
TROW
$25B
$35.8M 0.05%
310,217
-304,706
-50% -$35M
ELV icon
327
Elevance Health
ELV
$81.9B
$35.8M 0.05%
+66,000
New +$34.9M
HAL icon
328
Halliburton
HAL
$27.9B
$35.4M 0.05%
1,048,793
+684,413
+188% +$25.3M
NOW icon
329
ServiceNow
NOW
$102B
$35.2M 0.05%
223,500
-140,255
-39% -$20.6M
TXN icon
330
PUT
Texas Instruments
TXN
$255B
$35M 0.05%
+180,000
New +$33.3M
FDX icon
331
PUT
FedEx
FDX
$74.5B
$34.7M 0.05%
+115,600
New +$30.2M
ITCI
332
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$34.2M 0.05%
+499,015
New +$34.6M
PCG icon
333
PG&E
PCG
$47.8B
$34M 0.05%
1,946,520
+1,880,542
+2,850% +$33.1M
AIZ icon
334
Assurant
AIZ
$13.7B
$33.9M 0.05%
203,778
+31,150
+18% +$5.4M
JHG
335
DELISTED
Janus Henderson
JHG
$33.7M 0.05%
1,000,823
+327,819
+49% +$10.7M
AMG icon
336
Affiliated Managers Group
AMG
$9.46B
$33.6M 0.04%
215,059
-71,189
-25% -$11.3M
CRGY icon
337
Crescent Energy
CRGY
$3.72B
$33.5M 0.04%
2,830,118
+2,098,303
+287% +$24.7M
FLEX icon
338
Flex
FLEX
$43.4B
$33.5M 0.04%
1,136,410
+331,027
+41% +$9.91M
COLD icon
339
Americold
COLD
$4.09B
$33.5M 0.04%
1,311,063
+186,145
+17% +$4.56M
BILL icon
340
BILL Holdings
BILL
$4.33B
$33.5M 0.04%
635,937
+77,508
+14% +$4.39M
X
341
DELISTED
US Steel
X
$33.4M 0.04%
882,802
-1,459,060
-62% -$55.7M
ZS icon
342
Zscaler
ZS
$23B
$33.4M 0.04%
173,616
-414,580
-70% -$73.8M
COP icon
343
ConocoPhillips
COP
$147B
$33.1M 0.04%
+289,632
New +$35.2M
AMBA icon
344
Ambarella
AMBA
$2.99B
$33.1M 0.04%
613,346
+250,778
+69% +$12.5M
ISRG icon
345
Intuitive Surgical
ISRG
$121B
$32.9M 0.04%
73,927
-580,213
-89% -$231M
WRK
346
DELISTED
WestRock Company
WRK
$32.8M 0.04%
653,380
+10,612
+2% +$536K
AAPL icon
347
PUT
Apple
AAPL
$4.89T
$32.6M 0.04%
154,900
-730,000
-82% -$136M
CRWD icon
348
CrowdStrike
CRWD
$187B
$32.6M 0.04%
340,228
+301,804
+785% +$25.1M
PBR icon
349
Petrobras
PBR
$121B
$32.5M 0.04%
2,245,998
-164,733
-7% -$2.56M
IWM icon
350
PUT
iShares Russell 2000 ETF
IWM
$80.9B
$32.5M 0.04%
160,000
-512,000
-76% -$103M

Similar funds

Marshall Wace's Q2 2024 Portfolio in Review

As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.

  • Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
  • Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
  • Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
  • Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
  • Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
  • Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.

Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.